SG
REGN icon

StoneX Group’s Regeneron Pharmaceuticals REGN Stock Holding History

StoneX Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$561K Buy
+891
New +$606K 0.02% 517
2024
Q4 		– Sell
-218
Closed -$229K – 920
2024
Q3 		$229K Buy
+218
New +$243K 0.02% 550
2024
Q2 		– Sell
-235
Closed -$226K – 727
2024
Q1 		$226K Sell
235
-42
-15% -$39.9K 0.02% 502
2023
Q4 		$243K Buy
277
+27
+11% +$22.2K 0.02% 475
2023
Q3 		$206K Buy
+250
New +$196K 0.02% 522
2023
Q2 		– Sell
-334
Closed -$274K – 721
2023
Q1 		$274K Buy
+334
New +$252K 0.03% 434
2022
Q2 		– Sell
-410
Closed -$286K – 802
2022
Q1 		$286K Buy
410
+33
+9% +$20.9K 0.02% 481
2021
Q4 		$238K Sell
377
-104
-22% -$63.9K 0.03% 466
2021
Q3 		$291K Sell
481
-6
-1% -$3.73K 0.04% 368
2021
Q2 		$272K Buy
487
+10
+2% +$5.07K 0.04% 383
2021
Q1 		$226K Sell
477
-32
-6% -$15.6K 0.04% 366
2020
Q4 		$246K Buy
509
+5
+1% +$2.7K 0.05% 307
2020
Q3 		$282K Buy
504
+23
+5% +$13.9K 0.09% 241
2020
Q2 		$300K Sell
481
-30
-6% -$17K 0.11% 216
2020
Q1 		$250K Buy
+511
New +$211K 0.13% 200
2018
Q3 		– Sell
-674
Closed -$233K – 244
2018
Q2 		$233K Buy
+674
New +$211K 0.2% 196
2017
Q3 		– Sell
-704
Closed -$346K – 318
2017
Q2 		$346K Buy
+704
New +$308K 0.11% 250

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

StoneX Group's REGN Position: Q2 2026 in Review

StoneX Group opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 891 shares worth $561K. The stake represents 0.02% of the portfolio and ranks #517 among its holdings. This is a return to the name: StoneX Group previously reported a position in REGN as recently as Q3 2024.

StoneX Group first reported a position in REGN in Q2 2017 and has held it in 17 quarters since. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • StoneX Group held 891 shares of Regeneron Pharmaceuticals worth $561K as of Q2 2026.
  • Regeneron Pharmaceuticals was a new StoneX Group position in Q2 2026.
  • Regeneron Pharmaceuticals made up 0.02% of StoneX Group's portfolio in Q2 2026, its #517 holding.
  • StoneX Group first reported a position in Regeneron Pharmaceuticals in Q2 2017 and has held it in 17 quarters since.
  • 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.